C M Asplin
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Nephrology top 10%
- Renal Diseases and Glomerulopathies
Papers in
-
- Diabetes Management and Research 11
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 6
- Diabetes Treatment and Management 4
- Genetics 8
- Diabetes and associated disorders 8
- Co-authors
- Thomas L. Paquette (1 shared paper)M. Hartog (8 shared papers)John Verrier Jones (1 shared paper)D. J. Goldie (6 shared papers)Iain D. C. Fraser (1 shared paper)Paul J. Davis (1 shared paper)R C Bucknall (1 shared paper)Terry J. Hamblin (1 shared paper)
- Journals
- Diabetologia (4 papers)The Lancet (3 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)European Journal of Endocrinology (2 papers)Experimental Biology and Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesNew Zealand
In The Last Decade
C M Asplin
27 papers receiving 616 citations
Peers
Comparison fields: 5 of 79
- Endocrinology, Diabetes and Metabolism 252
- Nephrology 43
- Genetics 170
- Rheumatology 83
- Immunology 107
Countries citing papers authored by C M Asplin
This map shows the geographic impact of C M Asplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C M Asplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C M Asplin more than expected).
Fields of papers citing papers by C M Asplin
This network shows the impact of papers produced by C M Asplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C M Asplin. The network helps show where C M Asplin may publish in the future.
Co-authors
The 25 scholars most cited alongside C M Asplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 176 | |
| 2 | 1991 | 95 | |
| 3 | 1981 | 92 | |
| 4 | 1976 | 44 | |
| 5 | 1982 | 39 | |
| 6 | 1978 | 33 | |
| 7 | 1993 | 33 | |
| 8 | 1983 | 21 | |
| 9 | 1996 | 19 | |
| 10 | 1978 | 17 | |
| 11 | 1979 | 15 | |
| 12 | 1980 | 14 | |
| 13 | 1976 | 12 | |
| 14 | 1979 | 12 | |
| 15 | 1976 | 12 | |
| 16 | 1977 | 10 | |
| 17 | 1978 | 10 | |
| 18 | 1984 | 9 | |
| 19 | 1991 | 9 | |
| 20 | 1977 | 9 |
About C M Asplin
C M Asplin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Physiology and Molecular Biology, having authored 27 papers that have together received 707 indexed citations. Recurring topics across this work include Diabetes Management and Research (11 papers), Diabetes and associated disorders (8 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers), Pancreatic function and diabetes (5 papers), Diabetes Treatment and Management (4 papers), Diet and metabolism studies (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (252 citations), Nephrology (43 citations), Genetics (170 citations), Rheumatology (83 citations) and Immunology (107 citations). C M Asplin has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Thomas L. Paquette, M. Hartog, John Verrier Jones, D. J. Goldie, Iain D. C. Fraser, Paul J. Davis, R C Bucknall, Terry J. Hamblin, G László and R. H. Cumming. Their work appears in journals such as Diabetologia, The Lancet, The Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.